1. Home
  2. Africa
  • News

Better adherence to AIDS drugs than US

Evidence has emerged that HIV-positive people in Africa follow their antiretroviral drug regimens more closely than their American counterparts.

Contrary to sceptical views that HIV/AIDS treatment in Africa was not feasible, research shows that HIV-positive people in Botswana, Uganda, Senegal and South Africa take 90 percent of their drug regimens, compared to America's 70 percent.

Dr David Bangsberg, a professor of medicine at the University of California San Francisco, said on average, US patients told their doctors they were 20 percent better in adhering to their regimens than they actually were.

However, a study of 29 people living with HIV/AIDS in Uganda found that while the respondents estimated taking 93 percent of their pills, in reality it was 91 percent.

The New York Times quoted Bangsberg as saying: "Most Africans are zealous about adhering to their drug regimens and are more truthful than their US counterparts when estimating their adherence to a drug regimen."


This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join